The difference between the two highlights ways to improve the journey through care for all parties. We’ll explore this and more in our next report.
Does Healthcare Serve Consumers or Patients?
read more
HIMSS’21: Finding Value in a Shifting Landscape
HIMSS’21 looked and felt much different this year. Fewer attendees meant more gaps on the floor, but came with deeper insights and surprising value.
Introducing the Chilmark Research Future of Health IT Map
Chilmark’s new Healthcare IT Map will provide a comprehensive graphical look at trends, drivers, big stories, and wildcards in the Health IT market.
May 2021 Recap
Top Chilmark content from May So What? Your Guide to the Biden Administration's Key Health IT...
Digital Therapeutics: Market Issues for an Emerging Technology [Chilmark Monitor]
Digital Therapeutics (DTx) entered the discourse of digital health nearly a decade ago but have yet to reach a broad consumer market due to lack of mature payment models and support from PBMs. The mainstreaming of DTx at the consumer level still has a distance to go to reach mainstream consumers and lack of payment models is one of the primary constraints.
HHS Appointees and Health IT: What to Expect from the New Administration
Take a look at these current cabinet officials, both newly appointed and those who have stayed on, and their potential impact on the health IT landscape.
April 2021 Recap
Top Chilmark content from April: Integration Infrastructure: Building 21st Century Healthcare IT...
2021Q2 Client Update [Advisory Service]
Join us for our second Quarterly Update of 2021 as our team shares key takeaways from a rather exciting and intense first quarter in the world of healthcare and health IT. Hear updates on the market and what this means for you and your organization as the industry continues to evolve. Use the timestamps below to jump to different sections of the broadcast.
2020 Healthcare IT: Not All Doom and Gloom
Most health IT companies suffered as projects were shelved and the RFP pipeline shut-down so health systems could grapple with the surge in COVID cases coming through their doors. Most public health IT companies stopped providing forward guidance to Wall Street investors, and many companies slashed their workforces. But like most things in life, there are exceptions to every rule.